Trials / Completed
CompletedNCT01131780
Bioequivalency Study of Ibuprofen 200 mg and Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's Under Fasting Conditions
A Randomized, Open Label, 2-treatment, Single Dose, Crossover, Bioequivalence Study of Ibuprofen 200 mg+Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's and Advil® Cold and Sinus Caplets of Wyeth Consumer Healthcare Under Fasting Conditions.
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Dr. Reddy's Laboratories Limited · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg under fasting conditions.
Detailed description
This study assess the bioequivalence of Ibuprofen 200 mg + Pseudoephedrine HCL 30 mg Tablets of Dr. Reddy's and Advil® Cold and Sinus Caplets of Wyeth Consumer Healthcare in healthy human adult subjects with the single oral administration under fasting conditions with a washout period of 7 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ibuprofen + Pseudoephedrine Hydrochloride | Ibuprofen 200 mg + Pseudoephedrine Hydrochloride 30 mg Tablets |
Timeline
- Start date
- 2004-10-01
- Primary completion
- 2004-10-01
- Completion
- 2004-11-01
- First posted
- 2010-05-27
- Last updated
- 2010-06-14
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT01131780. Inclusion in this directory is not an endorsement.